Skip to main content

UFLPA to impact global chemical supply chains

18th July 2022

Submitted by:

Andrew Warmington

Oliver Cushing, CEO of RightsDD, looks at the possible impact of a new US law on the chemical industry

On 21 June, the Uyghur Forced Labor Prevention Act (UFLPA) came into force. It effectively bans the import of any good mined, produced or manufactured in the Xinjiang region of China to the US. Significantly, the ban extends to goods containing any material mined, produced or manufactured in the region. The new law has far reaching consequences for chemical companies, because many goods sourced from China are likely to be made in, or contain materials from, Xinjiang.

The US government believes that Uyghurs and other ethnic minority groups are being exploited at scale in other regions of China as part of a government run ‘poverty alleviation’ programme. The import of goods made, or containing materials made, by such workers is also prohibited.

Forced labour prohibition & the UFLPA

The import into the US of goods mined, produced or manufactured by forced labour has been prohibited since 1930. US Customs & Border Protection (CBP) can detain and destroy suspect goods and fine importers. The CBP has significantly stepped up enforcement in recent years. In 2021 they detained 1,469 shipments on forced labour grounds compared to just six in 2018. RightsDD, a human rights due diligence technology and consultancy company, predicts that shipment detentions will be two to five times the 2021 figure in 2022.

The UFLPA creates a ‘rebuttable presumption’ whereby any good mined, produced or manufactured in full or part in Xinjiang will be treated as the product of forced labour. Unless the importer can demonstrate that the good was not made by forced labour, it will be detained and potentially destroyed at US ports. The importer may also be fined. Goods that do not contain Xinjiang-sourced materials, but which are processed in facilities that handle materials from Xinjiang, may also be detained by CBP under the ‘commingling principle.’

Xinjiang

Xinjiang is China’s largest region and is nearly four times the size of California. Its population is equivalent to that of Australia and its economy is about the same size as Finland’s. Approximately 12 million of Xinjiang’s 26 million people are ethnic Uyghurs, a traditionally Muslim group with a distinct language and culture. Other traditionally Muslim groups in Xinjiang number nearly three million.

The US Government asserts, based on multiple credible investigations, that the Chinese Government has “since 2017, arbitrarily detained as many as 1.8 million Uyghurs, Kazakhs, Kyrgyz, and members of other Muslim minority groups in a system of extrajudicial mass internment camps, in addition to arbitrarily detaining many in formal prisons and detention centres, and has subjected detainees to forced labour, torture, political indoctrination and other severe human rights abuses.”

Xinjiang’s chemical sector Xinjiang plays a significant role in China’s speciality chemicals sector, both as a place of manufacture and a source of ingredients. Furthermore, that role is likely to expand. Emily de la Bruyere of China-focused risk consultancy Horizon Advisory noted that “the chemical industry is a priority, and growing priority, in the Chinese government’s industrial policy in Xinjiang; the Xinjiang Production and Construction Corps sees the chemical industry as key to developing the regional economy.”

The South China Morning Post reports that the top export by value from Xinjiang to the US in Q1 2021 was a heterocyclic compound widely used in cancer drugs. The second was amino acids.1 About 20% of China’s hydrocarbon production comes from Xinjiang. Xinjiang has a large commodity chemical sector and its outputs will be used to make many of China’s speciality chemicals. Notably the region produces 5% of China’s ethylene, 8% of the country’s caustic soda and 26% of its calcium carbide. In total the region exported €1 billion of chemicals goods overseas in 2019.

Direct exports are probably the tip of the iceberg, however. Companies should be equally concerned by the risk that goods made in other parts of China contain materials sourced from Xinjiang. Xinjiang also looms large in the supply chain of auxiliary materials that chemicals companies buy. For example, the region produces 7% of China’s plastic and packaging sourced from the country has a high risk of coming from Xinjiang.

Essential steps for companies

The UFLPA is the latest in a series of new American, Australian, British and EU regulations that target modern slavery, including forced labour, in business supply chains. To comply with the new regulations, companies need to implement human rights due diligence of their supply chains.

Indeed, the benefits of implementing due diligence go well beyond compliance. Customers, employees and investors alike expect companies to take reasonable steps to ensure that their supply chains are not propped up by human rights abuses, including forced labour.

The due diligence process involves engaging with stakeholders, assessing risks, and monitoring risks. Companies should ask their suppliers whether goods come from Xinjiang or contain materials from the region. This is a key but insufficient step on its own, given the obvious potential for suppliers to obfuscate. They should therefore map and trace supply chains and employ third party data to determine the forced labour risk profile of given goods and suppliers.

Companies should also incorporate human rights requirements into supplier codes of conduct, add appropriate clauses to supplier contracts and train employees to spot indicators of forced labour. Those who fail to conduct due diligence of supply chains for modern slavery will increasingly expose themselves to legal, reputational and operational risk. They also risk the ire of consumers, employees and investors alike.

Contact:

Oliver Cushing

CEO

RightsDD

[email protected]

www.rightsdd.com

Reference:

1. https://www.scmp.com/economy/china-economy/article/3130567/china-trade-xinjiang-exports-us-doubled-first-quarter-even

Feature article – Saltigo rides out the cycle

Market and sustainability trends are positive drivers for Saltigo, despite the agro downturn. Andrew Warmington met up with the new CEO at Chemspec Europe

Submitted by:

Andrew Warmington

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical active ingredient (AI) manufacturing to its wholly owned subsidiary UPL Spec

Submitted by:

Andrew Warmington

Nippon Shokubai opens Indonesian plant

Japan’s Nippon Shokubai has officially opened a 100,000 tonnes/year acrylic acid (AA) plant that was built at a cost of about $200 million at Cilegon, Banten, Indonesia.

Submitted by:

Andrew Warmington

CABB to invest at Finnish agro site

The CABB Group has said that it will invest over €50 million by 2025 to expand facilities at its agrochemical manufacturing site in Kokkola, Finland.

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production planning of superabsorbent polymers (SAPs) based on acrylic acid, and has started operati

Submitted by:

Andrew Warmington

adcs

Three invest further into ADCs

Three CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic.

Submitted by:

Andrew Warmington

Cambrex exits drug product

CDMO Cambrex has sold its Drug Product business unit to Noramco. Terms were not disclosed.

Submitted by:

Andrew Warmington

Siegfried breaks ground on R&D centre

Siegfried has broke ground for its new global R&D centre for drug substances at its site in Evionnaz, Switzerland.

Submitted by:

Andrew Warmington

Drug product centre opens

Following two years of construction work, CDMO Siegfried has officially opened its new development centre for drug products at its sites in Barberà del Vallès and El Masnou near Barcelona.

Submitted by:

Andrew Warmington

Evonik realigns Health Care

In order to “maximise customer centricity and market focus” and continue an ongoing transition into “a system solutions partner for the pharmaceutical and biotech industries”, Evonik has divided it

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants under the trade names AmphiCare and AmphiClean.

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based subsidiary of Seqens.

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in Austria have co-developed a computer-assisted regression model to improve enzyme performance and

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU and the Bio-based Industries Consortium (BIC) that funds projects advancing competitive circular bi

Submitted by:

Andrew Warmington

Investment in Tanasote plant

Octowood, a part of the Sweden’s Rundvirke Industrier Group, has invested in a new treatment plant using Arxada’s wood preservative, Tanasote.

Submitted by:

Andrew Warmington

Rhamnolipid milestone reached

Evonik has manufactured the first product from its industrial-scale biosurfactants facility at Slovenská Lupca in Slovakia.

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach Group in a move that it said would “create a global pigment company, combining SCIL’s ope

Submitted by:

Andrew Warmington

Lanxess to continue pigment production

Lanxess has reversed a decision to sell the chromium oxide pigments business at the Krefeld-Uerdingen site in Germany, preserving 50 jobs there.

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw materials, has announced a strategic collaboration with Japan’s Takasago, a large player in th

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site in Guangzhou. This triples its manufacturing capacity for fragrances and establis

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable fragrance ingredients from renewable carbon, with US-based LanzaTech, which describes i

Submitted by:

Andrew Warmington

Kao boosts jasmine fragrance

Japan's Kao Corporation is to double capacity for the synthetic fragrance methyl dihydrojasmonate (MDJ) at its site in Olesa, Spain, by adding a second production facility.

Submitted by:

Andrew Warmington

Merck KGaA “in a strong strategic position”

At its latest Capital Markets Day, Merck KGaA said that it is “in a strong strategic position” to profit from medium-term growth opportunities in all three of its business sectors after a transitio

Submitted by:

Andrew Warmington

Suez joins Global Impact Coalition

Suez, which describes itself as “a global leader in circular solutions for water and waste”, has joined the Global Impact Coalition (GIC).

Submitted by:

Andrew Warmington

Chemours opens battery lab

Chemours has opened Chemours Battery Innovation Centre (CBIC) at the Chemours Discovery Hub in Newark, Delaware.

Submitted by:

Andrew Warmington